Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.39 - $6.36 $3.25 Million - $4.71 Million
740,935 Added 143.8%
1,256,200 $5.9 Million
Q1 2024

May 15, 2024

BUY
$5.3 - $7.61 $88,854 - $127,581
16,765 Added 3.36%
515,265 $2.92 Million
Q4 2023

Feb 13, 2024

BUY
$4.5 - $7.51 $1.26 Million - $2.1 Million
279,000 Added 127.11%
498,500 $3.3 Million
Q3 2023

Nov 13, 2023

BUY
$7.85 - $10.68 $1.72 Million - $2.34 Million
219,500 New
219,500 $1.76 Million

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $55.9M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track Paradigm Capital Management Inc Portfolio

Follow Paradigm Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Capital Management Inc with notifications on news.